Abstract
The transmission control of the newly emerged severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the most effective strategy by the absence of its specified vaccine or drug. Although the aerosol mediated transmission of SARS‐CoV‐2 has been confirmed, the physicochemical treatment of the biotic and abiotic objects is still the most promising approach in its infection control. The front line of the most effective disinfecting compounds on SARS‐CoV‐2 implies to be sodium hypochlorite, ethanol, hydrogen peroxide, quaternary ammonium compounds, and phenolic compounds, respectively. However, widely used compounds of alkyldimethylbenzylammonium chloride (benzalkonium chloride) biguanides (chlorhexidine) have not shown the multitude load reduction in less than 10 minutes. The susceptibility of SARS‐CoV‐2 to physical treatment follows the pattern of heat, acidity, and UV radiation. Rather all of the mentioned physical or chemical treatments, target the envelope proteins of the coronavirus mainly by impairing its entry to host cells. The anti‐SARS‐CoV‐2 activity of combinatorial physicochemical treatments or evaluation of new chemical entities or physical treatments such as microwave irradiation still needs to be explored. Therefore, the development of a reliable decontamination protocol for SARS‐CoV‐2 demands revealing its stability pattern study vs a spectrum of single and combinatorial physicochemical parameters.
Keywords: antiseptics, anti‐viral, biocides, biosafety, coronavirus, disinfection, sanitization, SARS‐CoV‐2

Abbreviations
- CDC
Centers for Disease Control and Prevention
- EPA
Environmental Protection Agency
- HCl
hydrochloric acid
- H‐CoV
human coronavirus
- MERS
Middle East Respiratory Syndrome
- RT
room temperature
- SARS
Severe Acute Respiratory Syndrome coronavirus
- SARS‐CoV‐2
Corona Virus Disease 2019
- UV
ultraviolet
1. INTRODUCTION
Over the past two decades, Severe Acute Respiratory Syndrome (SARS‐CoV‐1), Middle East Respiratory Syndrome (MERS‐CoV), and recently SARS‐CoV‐2 coronaviruses have been for the causative agents of three epidemics around the world. The fourth epidemic of the human Coronavirus (H‐CoVs), SARS‐CoV‐2, led to a pandemic with 1 152 604 death in 213 countries till August 31, 2020 1 with an overall mortality rate of 6.8% and up to 14.8% in elderly patients. 2
Since the emergence of the new human coronavirus in the Wuhan at the end of December 2019, the focus of worldwide research is channeled to confine the effective ways to limit the outbreak of the virus till its effective drug and vaccination are developed. Although maintaining the conventional hygiene protocols is the approach in prophylaxis of all infections including the recent coronavirus outbreak, the most effective cleaning and disinfection practices of skin and surfaces are preferred to be followed in the clinic and society. 3 Confining the spread of the virus can minimize the risk of human infection and the environmental toxicity associated with long‐term usage of disinfectants in the upcoming months of lacking the vaccine or drugs of SARS‐CoV‐2.
Since the beginning of the pandemic, several reports have been published on disinfectants affecting coronaviruses, and a systematic review on the physicochemical susceptibility of the SARS‐CoV‐2 was targeted in this review. In this paper, in addition to summarizing the available information in the field of disinfectants and physical treatments on SARS‐CoV‐1, MERS‐CoV, and SARS‐CoV‐2, a hierarchical categorization is presented based on the effective contact time and the virus titer reduction. This classification appears to be useful in selecting effective disinfectants for effective prophylaxis of virus dissemination.
This study summarizes the effectiveness of the physical and chemical agents in reducing the stability and infection of human coronavirus published so far to recommend a balanced prophylaxis protocol for SARS‐COV‐2.
2. BIOLOGICAL CHARACTERISTICS OF THE CORONAVIRUS
Coronaviruses are classified in the subfamily Orthocoronavirinae from the family Coronaviridae, in the order Nidovirales as +ssRNA enveloped virus. 4
Although most of the H‐CoVs) cause typically mild respiratory tract infections and the common cold in humans, the nonhuman adapted forms (SARS‐CoV, MERS‐CoV, SARS‐CoV‐2) are pathogenic. 5 A high tropism to the respiratory tract cells is observed by SARS‐CoV‐2, which leads to severe sometimes irreversible lung injury by colonization in these cells and eventually acute respiratory syndrome. Binding to specific receptor (the angiotensin‐converting enzyme 2) together with proteolytic activation of spike protein in the presence of endosomal low pH is among the important factors that allow the attachment of the SARS‐CoV‐2 fusion peptide into target cell membranes. Therefore, the coating structures involved in attachment and entry in the initial stage of infection are the pivotal targets of antiviral drug discovery efforts for SARS‐CoV‐2. 6
3. TRANSMISSION OF SARS‐COV‐2
The causative agent of SARS‐CoV‐2 seems to be spreading sustainably to all countries soon. It has been found that there is a direct relationship between population density in public places, transportation, and SARS‐CoV‐2 distribution pattern. The indirect SARS‐CoV‐2 transmission occurs through the release of the virus from an infected person to the skin or surfaces, and eventually to the next person's mucous membranes (eyes, nose, or mouth). 7 Furthermore, a study in China demonstrates coherency between the SARS‐CoV‐2 contagion rate and the type of vehicle used for transportation by 68.72% and 11.85% of infection transmission when trafficking by train and car, respectively. 8 The main way of coronaviruses spread is a person‐to‐person transmission with the incubation times between 1 and 14 days, which occurs in direct and indirect contacts or via respiratory droplets. 9 Based on previous evidence, the transmission of H‐CoVs and presumably SARS‐CoV‐2 is influenced by parameters such as flow and density of the population, immunity of the human host, climate variations like high temperature and higher relative, or absolute humidity. 10 , 11 Investigation of globally meteorological conditions also indicates that calm, cold, dry, and overcast conditions can be favorable to the SARA‐CoV‐2 transmission. 10
4. PERSISTENCE OF CORONAVIRUS TO PHYSICAL ENVIRONMENTAL PARAMETERS
Due to the high genetic similarity of SARS‐CoV‐2 with SARS‐CoV‐1 and MERS‐CoV, 12 physical treatments for other members of its own family are expected to have a similar effect on SARS‐CoV‐2. Although, it is generally deduced that coronavirus strains have a limited tolerance and survival capacity on dry surfaces. Nevertheless, some studies confirmed that the strains with high pathogenicity, SARS‐CoV‐1, SARS‐CoV‐2, and MERS‐CoV remain infectious in drought conditions ranging from 2 hours to 28 days dependent on the type of surfaces and relative humidity (RH) on different nonbiologic materials at room temperature (RT). 13 , 14
In principle, H‐CoVs have the potential to retain their infectivity in various environmental reservoirs like surface water and untreated water, food materials, sewage and in general, on a wide range of biological and nonbiological materials, including many types of smooth and porous materials such as metals, woven, paper, ceramic, wood, glass, formica, tiles tissue, and feathers. 15 A new investigation reported that the SARS‐CoV‐2 can remain viable on paper and tissue paper, air, copper, cloth and wood, cardboard, and plastic for up to 30 minutes, 3, 4, 24, and 72 hours, respectively. 14 , 16 By contrast, SARS‐CoV‐2 is more stable on smooth surfaces such as plastics and stainless steel (for 4 days) and Banknote (for 2 days). Notably, SARS‐CoV‐2 can be infective on the inner and outer layer of face mask up to 4 and 7 days, respectively. 14
In addition to the intrinsic nature of the surfaces some other critical factors including, strain variations, imposed titer, temperature, pH, irradiation, and humidity influence the persistence and survival of H‐CoVs. 13 In general, H‐CoVs are more resistant to ambient humidity and acidity than to heat treatment and UV radiation (Figure 1). The decrease in temperature coupled with the increase in RH support the coronavirus infectivity for a longer time. 17 Although, the survival of this viral group, and especially SARS‐CoV‐2, generally decreases at temperatures of 30°C to 40°C, they can remain viable and infective for up to 28 days at temperatures around 4°C to 20°C. 18 The HCoV‐229E persists significantly longer in 50% RH compared to the 30% humidity at RT. Also, the reported survival times for SARS‐CoV‐1 vary between 1 day (80%‐95% RH at 33°C) and 28 days (40%‐50% RH at RT). 19 Similarly, Bu et al reported that SARS‐CoV‐2 can maintain its transmissibility and infectivity from 13°C to 19°C in humidity of 50% to 80% for 1 to 7 days dependent on the material of virus‐infected surfaces. 20 Recently, chin et al showed that only a 0·7 log10 reduction of virus infectious titer was observed after 14 days incubation at 4°C. 14
FIGURE 1.

Stability trend of the virus exposed to physicochemical stress is indicated by fading the color intensity of the virus. As shown, the detergents and disinfectants are the most detrimental treatments for SARS‐CoV‐2. In contrast, exposure to physical treatment has less efficiency in reducing the viral infectivity. Many members of the coronavirus can survive for 7 to 28 days at the low relative humidity (20%‐40%) and dry conditions at room temperature (20°C‐21°C). They are also resistant to a wide range of pH changes (3‐12). While, increasing the temperature to 75°C reduces the viral load to ≥5 log10 in less than 10 minutes. The viral particles of SARS‐CoV‐2 become undetectable in less than 10 minutes at 4016 μW/cm2 of UV radiation 44
5. UNIVERSAL ANTIVIRAL DISINFECTANTS
During the varied wave of H‐CoVs irruption within the recent decade, some universal guidelines have been published by WHO, CDC, and other authorities as recommendations of disinfection procedures for the management of coronavirus. European Standard (NF EN 14476 + A1) is one of the commonly implemented valid suspension protocols for assessment of virucidal activity that is routinely applied to measure the effectiveness of antiseptic and disinfectant products on enveloped and nonenveloped viruses. Based on this universal standard, the detectable titer reduction of an active compound on coronavirus must be at least four logarithmic titer reductions. 21
The main antiviral targets of skin and surface disinfectants are the three‐dimensional macromolecule structures of the virus, capsid proteins degradation, and genomic segmentation. These functional impairments are dependent on the type of disinfectant and their specific chemical change mechanism. 22 Although little information is available about SARS‐CoV‐2 behavior in the presence of virucidal compounds, it is assumed that it should be prone to disinfectants–antiseptics with proven activity on other members of the Coronaviridae or enveloped viruses.
5.1. Skin disinfection of the coronavirus
The skin contamination may occur by direct contact with patient secretions or indirectly from contact with the high‐touch surfaces that have become contaminated with dispersed droplets. The exact surviving time of H‐CoVs on human skin is still not specifically determined but it can stay long enough to spread from person to person. 23 There is a limited study on the virucidal antiseptics of SARS‐CoV‐2 and most available data only origin SARS‐CoV‐1 and H‐CoV 229E (Table 1).
TABLE 1.
The concentrations of antiseptic agents required to inactivate the human coronavirus (H‐CoV) on skin
| Category | Compound | Tested concentration | H‐CoV strain | Required contact time | Log redaction rate | References |
|---|---|---|---|---|---|---|
| Alcohol based compounds | 2‐propanol | 100% | SARS‐CoV‐1 | 30 s | ≥ 3.3 | 24 |
| 75% | SARS‐CoV‐1/MERS‐CoV | 30 s | ≥4.0 | 25 | ||
| 70% | SARS‐CoV‐1 | 30 s | ≥ 3.30 | 24 | ||
| Ethanol | 95% | SARS‐CoV‐1 | 30 s | ≥5.50 | 26 | |
| 85% | ||||||
| 80% | SARS‐CoV‐1 | ≥4.30 | ||||
| MERS‐CoV | > 4.0 | 25 | ||||
| 78% | SARS‐CoV‐1 | ≥ 5.0 | 24 | |||
| 70% | H‐CoV229E | 1 min | 3.9 | 27 | ||
| SARS‐CoV‐2 | 5 mins | Undetectable | 19 | |||
| 2‐propanol + 1‐propanol | 45% + 30% | SARS‐CoV‐1 | 30 s | ≥ 2. 8 | 24 | |
| ≥4.3 | 26 | |||||
| Isopropanol + glycerol + hydrogen peroxide | 75% + 1.45% + 0.125% | SARS‐CoV‐1/ MERS‐CoV | 30 s | Undetectable | 25 | |
| Ethanol + glycerol + hydrogen peroxide | 85% + 1.45% + 0.125% | |||||
| Isopropanol + glycerol + hydrogen peroxide | 75% + 0.725% + 0.125% | SARA‐CoV‐2 | 30 s | ≥5.9 | 28 | |
| Ethanol + glycerol + hydrogen peroxide | 85% + 0.725% + 0.125% | |||||
| Halogens | Povidone iodine (PVP‐I) | 0.23% | SARS‐CoV‐1,MER‐oV | 15 s | ≥4.4 | 29 |
| 2.3% to 7.5% | H‐CoV 229E/ MERS‐CoV | 15 s to 1 min dependent on concentration | > 3.0 to >5.0 dependent on concentration | 30 | ||
| 7.5% | SARS‐CoV‐2 | 5 mins | Undetectable | 19 | ||
| 30 s | ≥4.0 | 31 | ||||
| 10% | 30 s | ≥4.0 | ||||
| Biguanide based compounds | Chlorhexidine gluconate + ethanol | 0.1% + 70% | H‐CoV 229E | 1 min | ≥ 3 | 30 |
| Chlorhexidine gluconate + cetrimide + ethanol | 0.05% + 0.5% + 70% | H‐CoV 229E | 1 min | ≥ 3 | ||
| Chlorhexidine | 0.05% | SARS‐CoV‐2 | 5 mins | Undetectable | 14 | |
| Calixarenic derived compounds | Tetra‐para‐sulfonato‐calix[33]arene (C[33]S) | 0.1% | H‐CoV 229E | 5 mins | 3 | 32 |
| 1,3‐bis(bithiazolyl)‐tetra‐para‐sulfonato‐calix[33]arene (C[33]S‐BTZ) |
Note: Test strains include Middle East Respiratory Syndrome (MERS‐CoV), Severe Acute Respiratory Syndrome (SARS‐CoV‐1), and Severe Acute Respiratory Syndrome (SARS‐CoV‐2) H‐CoV 229E.
The denaturing and coagulation effect of alcohols on proteins makes them effective against a wide range of bacteria and viruses. As investigated in numerous studies, alcohols have demonstrated immediate, significant inhibitory effects against the majority of enveloped and nonenveloped viruses including the members of coronaviruses family. 33 Alcohol‐based hand sanitizers are widely considered to be effective to reduce or eliminate infectious microorganism, bacterial/viral load. Common alcoholic disinfectants such as ethanol, isopropanol, and n‐propanol are applied in the form of hand rub rinses, gels, and foams. It has been confirmed that ethyl alcohol diminishes the infectivity of coronavirus at concentrations of 78% to 95% within 30 seconds contact time by greater than 4.0 log10. 26 Additionally, WHO reports that alcohol‐based formulations (80% ethanol or 75% 2‐propanol) have completely inactivated SARS‐CoV‐1 and MERS‐CoV in suspension tests after 30 seconds of exposure time. 25 Moreover, a recent study has shown that >30% concentrations of ethanol and isopropanol were effective in inactivating SARS‐CoV‐2 within 30 seconds. 28 Among the compounds based on halogens, povidone‐iodine (PVP‐I) is widely available for medical and personal use. Based on the data obtained by quantitative assay, this compound shown rapid and effective virucidal activity against SARSCoV‐2 corresponding to ≥4 log10 reduction of virus titer, within 30 seconds of contact in all concentrations of 0.45%,1%, 7.5%, and 10%. 31 Undoubtedly, the use of these compounds as antiseptics can augment health and hygiene measures to limit the COVID‐19 separating in the community.
5.2. Surface inactivation of the coronavirus using chemical reagents
Among all conventional prophylaxis approaches, using surface disinfectants is one of the effective approaches for reducing the risk of exposure to SARS‐CoV‐2; although, its airborne nature is plausible. Therefore, one of the most drastic approaches that interrupt the coronaviruses and in particular, SARS‐CoV‐2 infection, is the tailored, suitable, and periodical disinfection of contaminated surfaces and equipment.
Although it is shown that enveloped viruses are in general more sensitive to the disinfectants than the nonenveloped viruses, coronavirus exhibit resistance to some conventional chemical disinfectants. 34 The human coronaviruses, including HCoV‐229E and SARS‐CoV‐1, as well as several animal coronaviruses (e.g., mouse hepatitis virus and transmissible gastroenteritis virus of pigs), have been used as coronavirus models to investigate and determine the activity of chemical disinfectants. As a result, among the candidates of formulated disinfectants against coronaviruses, just some of them have received the Environmental Protection Agency (EPA) confirmation. 35
In general, biocidal agents can be categorized in the nine groups including, acids, alcohols, oxidizing agents, aldehydes, phenols, alkalis, biguanides, halogens, and quaternary ammonium compounds, among which, hydrogen peroxide, alcohols, sodium hypochlorite, benzalkonium chloride, or biguanides are commonly used to disinfect the virus exposed suspected area, mainly in healthcare settings. 36 The virucidal activities of different disinfectants based on the so far investigations are summarized in Table 2. Some widely used disinfectants such as sodium hypochlorite and hydrogen peroxide show a significant activity on the H‐CoVs. Hydrogen peroxide as the most available compound is an effective surface disinfectant at a concentration of 0.5% by exhibiting more than 4.0 log 10 in viral titer. Sodium hypochlorite at concentrations of 0.1 to 0.5% and glutaraldehyde at the concentration of 2% have shown also significant viral titer reduction with >3.0 log10. 14 Nevertheless, in the case of chlorine‐derived compounds, regardless of their dose‐dependent effect on the H‐CoVs, their toxicity and detrimental effect on the ecosystems during this huge worldwide consumption must be considered.
TABLE 2.
The concentration of chemical disinfectant agents that inactivate the human coronavirus (H‐CoV) on surface and tools
| Category | Compound | Tested concentration | H‐CoV strain | Required contact time | Log reduction rate | Reference |
|---|---|---|---|---|---|---|
| Halogens | Benzalkonium chloride | 0.04% | HCoV‐ 229E | 1 min | < 3.0 | 30 |
| 0.1% | SARS‐CoV‐2 | 5 mins | Undetectable | 14 | ||
| Chloramine T | 0.3% | HCoV‐ 229E | 1 min | ≥ 3 | 30 | |
| Sodium hypochlorite | 0.1% ‐0.5% | HCoV ‐229E | 1 min | ≥ 3 | ||
| 0.05‐0.1% | SARS‐CoV‐1 | 5 mins | ≥ 3 | 37 | ||
| Sodium hypochlorite + potassium bromide | 0.05% to 0.1% | HCoV 229E | 1 min | ≥ 3 | 37 | |
| Sodium hypochlorite 5% | 1:45 | SARS‐CoV‐2 | 5 mins | Undetectable | 14 | |
| 1:99 | ||||||
| Aldehyde based compounds | Glutaraldehyde | 0.5% to 2.5% | SARS‐CoV‐1, HCoV 229E | 2 mins to 4 mins | > 4.0 | 26, 38 |
| Formaldehyde | 0.7% to 1% | SARS‐CoV‐1 | 2 mins to 24 h dependent on concentration | > 3.0 to >4.0 dependent on exposure time | 24 | |
| Glucoprotamin | 26% | SARS‐CoV‐1 | 2 mins | ≥ 1.68 | ||
| Oxidizing agents | Hydrogen peroxide | 0.5% | H‐CoV 229E | 1 min | > 4.0 | 39 |
| Quaternary ammonium compounds | n‐alkyl‐dimethylbenzyl chloride + HCl | 0.04 + pH 7.00 | H‐CoV 229E | 1 min | ≥ 3.0 | 30 |
| n‐alkyl‐dimethylbenzyl chloride + ethanol | 0.04% + 70% | H‐CoV 229E | 1 min | ≥ 3.0 | ||
| n‐alkyl‐dimethylbenzyl chloride + sodium metasilicate | 0.04% + 0.5% | HCoV 229E | 1 min | ≥ 3.0 | ||
| Alkyl dimethyl benzyl ammonium chloride | 0.077% | SARS‐CoV‐2 | 5 mins | ≥4.1 | 40 | |
| 0.19% | SARS‐CoV‐2 | 2 mins | ≥3.5 | |||
| Alkyl dimethyl benzyl ammonium saccharinate + ethanol | 0.083% + 50% | SARS‐CoV‐2 | 2 mins | ≥4.6 | ||
| Phenolic compounds | o‐phenylphenol + o‐benzyl‐chlorophenol + p‐tert‐amylphenol + SDS | 0.02% + 0.03% + 0.01% + 0.60% | HCoV 229E | 1 min | ≥ 3.0 | 30 |
| o‐phenylphenol + o‐benzyl‐chlorophenol + p‐tert‐amylphenol + ethanol | 0.02% + 0.03% + 0.01% + 70.0% | HCoV 229E | 1 min | ≥ 3.0 | ||
| Sodium o‐benzyl‐p‐chlorophenate + Sodium dodecyl sulfate | 0.50% + 0.60% | HCoV 229E | 1 min | ≥ 3.0 | ||
| Household detergent | Lauryl ether sulfate, alkyl polyglycosides, and coco‐fatty acid diethanolamide | 0.5% | SARS‐CoV‐1 | 5 mins | > 3.0 | 41 |
Note: The viral strains include Severe Acute Respiratory Syndrome (SARS‐CoV‐1), Severe Acute Respiratory Syndrome 2 (SARS‐CoV‐2), Middle East Respiratory Syndrome (MERS‐CoV), and Human coronavirus strain 229E (HCoV‐229E).
5.3. Surface inactivation of the coronavirus by physical treatments
Unlike many enveloped viruses that are sensitive to most of the physicochemical changes, less susceptibility of H‐CoVs to these changes has been demonstrated in some studies. 42 The majority of the physical treatments similar to chemical interventions agents inactivate the viruses via denaturation of its structural proteins and interference with the virus and host cell‐effective interaction. 22
A thermal disinfection program can be variable from 60°C, 65°C or 80°C, for 30, 15 and 1 minute, respectively. All of these schedules were efficacious to decrease the infectivity of H‐CoVs up to four logarithmic reductions. 43 Two H‐CoVs, SARS‐CoV‐1 and MERS‐CoV, can be completely inactivated at 65°C and 75°C after 15 minutes, respectively. 44 , 45 It is confirmed that inactivation of SARS‐CoV‐2 can be achieved after 5 minutes with the incubation temperature increased to 70°C. 46
The N protein of SARS‐CoV‐1 is substantially denatured at 55°C treatment for 10 minutes. 43 Also, it is suggested that extreme pH conditions can probably change the infectious nature of the viral particles and indirectly affect the attachment and fusion process of spike proteins to cell membranes. The alkaline (pH > 12) and acidic (pH <3) conditions can cause the inactivation of SARS‐CoV‐1 at 37°C while the viral articles remain infectious in pH range of 5 to 9. The optimum UV range for uppermost disinfection efficacy is between 245 and 285 nm. The complete deactivation effect of UV irradiation for a 6 minutes is reported for SARS‐CoV‐1 at 60 minutes at >90 μW/cm2. 19 , 41 As a similar susceptibility is assumed for SARS‐CoV‐2, it is recommended to use the UV radiation treatment in the compatible area to confine the environmental discharge of the chemical disinfectants (Table 3).
TABLE 3.
Effect of physical treatments including heat, acidity, UV and humidity conditions on the stability of Human coronavirus strain Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS‐CoV‐1), and Severe Acute Respiratory Syndrome 2 (SARS‐CoV‐2)
| Coronavirus strain | SARS‐CoV‐1 | MERS‐CoV | SARS‐CoV‐2 |
|---|---|---|---|
| Heat (°C) | Complete inactivation time by exposure to heat | ||
| 56 | 90 mins 41 | 30 mins 47 | 30 mins 48 |
| 60 | 90 mins 24 | ND | 60 mins 48 |
| 65 | 60 mins 24 | 15 mins 47 | ND |
| 70 | 60 mins 44 | ND | ND |
| 75 | 30 mins 37 | ND | ND |
| 92 | ND | ND | 15 mins 48 |
| pH | Stability/inactivation by exposure to extreme pH | ||
| ≤5 | Inactive 44 | Inactive 49 | Stable 50 |
| 7 | Stable 44 | Stable 49 | Stable 50 |
| 9 | Stable 44 | Stable 49 | Stable 50 |
| ≥12 | Inactive 44 | Inactive 49 | ND |
| UV‐C (nm) | Complete inactivation time by exposure to irradiation | ||
| 365 | 60 mins at >90 μW/cm2 44 | ND | ND |
| 254 | 6 mins at 4016 μW/cm2 44 | 5 mins 51 | 9 mins 52 |
| Relative humidity (%) | Stability time at room temperature | ||
| 40‐50 | 28 days 19 | 2 days 49 | ND |
| 60‐70 | ND | ND | 2‐7 days 17 |
| 80‐90 | 1 day 19 | 8 h 49 | ND |
| ˃ 95 | 1 day 19 | ND | ND |
Abbreviation: ND, not determined.
6. CONCLUSIONS
The highly infectious nature of SARS‐CoV‐2 has triggered an urge to investigating its susceptibility, transmissibility, and persistence, to reveal the most precise preventive measures against this new deadly virus. The stability duration of the virus on the surface is influenced by the physical parameters and can extend up to 28 days at RT under 20% to 40% RH. Despite their eventual inactivation by the time, the chemical interventions are required to neutralize their infectious capability before being transmitted to the next host in these days' duration.
Based on studies conducted till August 2020, the effective ingredients to H‐CoVs titer reduction can be graded based on Figure 2. As the schematic figure reflects, among the antiseptic compounds, alcohol‐based formulas can be considered as the most effective solutions. The solutions sodium hypochlorite 0.2% and hydrogen peroxide 0.5% are the most efficient and cost‐effective compounds for the purpose of abiotic disinfection in household and healthcare. Nevertheless, the interval usage of all these compounds is recommended by WHO and CDC protocols, 53 as their unprincipled and excessive consumption, in addition to skin and respiratory damage, can cause the loss of the individual's normal flora and, as a result, subsequent diseases by opportunistic viral and bacterial agents. 54
FIGURE 2.

Hierarchy of the virucidal efficacy of the pure chemical compounds on H‐CoV. Left: Antiseptics agents (on skin) and Right: Biocides (on abiotic surface and tools)
The effectiveness of the single antiseptic and biocide agents is often interpreted based on the intensity of the logarithmic load reduction and the time required for inactivation. However, some critical parameters should be considered such as the presence of organic materials namely the presence of interfering agents in antiseptic formulae such as the moisturizers or glycerin. Additionally, the protocol of disinfection for sample shipment and decontamination of SARS‐CoV‐2 samples in case of spilling needs to be published by the authorities.
The average of D90 values (UV energy that inactivates 90% of the exposed virus) for different strains of coronaviruses is 308 J/m2. Although this dose has not yet been determined for SARS‐CoV‐2, similar stability is expected. The surface cleaning precedent to the disinfectants such as sodium hypochlorite 0.2% and hydrogen peroxide 0.5%, followed by UV‐irradiation, is assumed to completely inactivate this group of infectious viruses including SARS‐CoV‐2. In addition, physical stress of acidic pH created by many of the EPA‐approved chemical antiviral reagents can have a synergistic effect with chemical reagents on inactivation of viral particles. 55 In contrary, the acidity condition may lead to neutralization of the antiviral compound or even the production of toxic byproducts.
As described in case of most viruses, the major inactivation mechanism by heat treatment is the denaturation of surface glycoproteins of enveloped viruses. As a result, host cell receptor‐detecting structures are out of reach by the virus, which reduce its infectivity. This magnified survival rate at low temperature may explain the winter propagation of coronaviruses and also the tropism of the virus to the respiratory system. Breathing cold air in winter may diminish the lung temperatures up to 5°C. 56 Since the bronchus is fully saturated with water vapor, these conditions provide an appropriate situation for coronaviruses viability and infection development. According to a recent study, it is demonstrated that SARS‐CoV‐2 can be detected in aerosols for up to 3 hours. This implies that treatments targeting airborne transmissions such as using UV radiation or the ozone gas must be more emphasized in parallel to the disinfection regimes. 16
7. FUTURE DIRECTIONS
The experimental data on sensitivity of SARS‐CoV‐2 to physical and chemical environmental parameters should be accumulated by the follow‐up studies to allow us to make precise designation of prevention methods. Up until now, the biosafety level 2 (BSL2) is acceptable for nonpropagative diagnostic research on SARS‐CoV‐2 while handling high concentration, propagation, or working on infected animals with coronavirus demands the requirements of Biosafety Level 3 (BSL3). Even this level of required core care and biosafety rules may be subjected to some changes by more upcoming data on transmission by aerosol and its susceptibly to chemical disinfection.
In forthcoming studies, the prioritization must be allotted to the survival time of the virus, which dramatically influences the probabilistic of the transmission. In contrast, the load reduction is more correlated to the high mass of the virus, which is not the case in most of the accidental spread and contamination of the virus specially from nonsymptomatic carriers.
The application of chemical disinfectants is the fastest and most efficient and irreversible treatment for attenuating the growth of the pandemic so far. One of the open fields of research is the investigation of a combination of the chemical disinfectant and obtaining the least effect concentrations. Moreover, the antiviral activity of the nanomaterial or natural compounds on the inactivation of the SARS‐CoV‐2 may also deliver some new potential effective compounds. The power unit and time necessary to inactivate the virus by microwave radiation or ozone vapor are also demanding to be described.
Furthermore, in such a massive worldwide usage of the disinfectants, the vast discharge and waste of these chemicals to the environment must have also be foreseen. At least, two types of studies can ameliorate this massive scale of chemical waste concern. The lines of studies that can diminish the required concentration or replace them with less toxic alternatives or the ones that introduce the decontamination and neutralization of these chemicals in discharged waste to the nature.
CONFLICT OF INTEREST
The authors declare no conflict of interest for the content of the paper.
AUTHOR CONTRIBUTION
Data collection and writing original draft: Fatemeh Saadatpour.
Conceptualization, data collection, review, and editing: Fatemeh Mohammadipanah.
All authors have read and approved the final version of the manuscript.
The corresponding author had full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis.
TRANSPARENCY STATEMENT
The authors declare that this manuscript is an accurate and transparent comparative overview of the published literature on the subject.
ACKNOWLEDGMENT
Authors would like to thank the support of Science and Technology Park of the University of Tehran (UTSTP). Funding is not applicable for the paper.
Saadatpour F, Mohammadipanah F. Physicochemical susceptibility of SARS‐CoV‐2 to disinfection and physical approach of prophylaxis. Health Sci Rep. 2020;3:e213 10.1002/hsr2.213
DATA AVAILABILITY STATEMENT
All the data reported in this manuscript are derived from published articles.
REFERENCES
- 1. Organization WH . Novel Coronavirus (2019‐nCoV): situation report, 2020 October 26.
- 2. Control CfD, Prevention . Hospitalization rates and characteristics of patients hospitalized with laboratory‐confirmed coronavirus disease 2019‐COVID‐NET, 14 States, March 1–30, 2020 [Internet]. Centers for Disease Control and Prevention; 2020. Morbidity and Mortality Weekly Report (MMWR).[Online] 2020; 4. p. 17. [DOI] [PMC free article] [PubMed]
- 3. Hulkower RL, Casanova LM, Rutala WA, Weber DJ, Sobsey MD. Inactivation of surrogate coronaviruses on hard surfaces by health care germicides. Am J Infect Control. 2011;39:401‐407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. King AM, Lefkowitz E, Adams MJ, Carstens EB. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses. Oxford, UK: Elsevier; 2011. https://www.sciencedirect.com/book/9780123846846/virus-taxonomy. [Google Scholar]
- 5. Xu Z. Can common coronavirus compete with novel coronavirus? 2020.
- 6. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin‐converting enzyme 2 (ACE2) as a SARS‐CoV‐2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586‐590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Song F, Shi N, Shan F, et al. Emerging 2019 novel coronavirus (2019‐nCoV) pneumonia. Radiology. 2020;295:210‐217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Zhao S, Zhuang Z, Ran J, Lin J, Yang G, Yang L. The association between domestic train transportation and novel coronavirus (2019‐nCoV) outbreak in China from 2019 to 2020: a data‐driven correlational report. Travel Med Infect Dis. 2020;33:101568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Pasqualoni SE. 2019 Novel Coronavirus (COVID‐19). Los Alamos, NM: Los Alamos National Lab (LANL); 2020. [Google Scholar]
- 10. Ma Y, Zhao Y, Liu J, et al. Effects of temperature variation and humidity on the death of COVID‐19 in Wuhan, China. Sci Total Environ. 2020;724:138226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Sungnak W, Huang N, Bécavin C, et al. SARS‐CoV‐2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681‐687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Phan T. Genetic diversity and evolution of SARS‐CoV‐2. Infect Genet Evol. 2020;81:104260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Casanova LM, Jeon S, Rutala WA, Weber DJ, Sobsey MD. Effects of air temperature and relative humidity on coronavirus survival on surfaces. Appl Environ Microbiol. 2010;76:2712‐2717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Chin A, Chu J, Perera M, et al. Stability of SARS‐CoV‐2 in different environmental conditions. medRxiv. 2020;1:e10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Warnes SL, Little ZR, Keevil CW. Human coronavirus 229E remains infectious on common touch surface materials. MBio. 2015;6:e01697‐e01615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS‐CoV‐2 as compared with SARS‐CoV‐1. N Engl J Med. 2020;382:1564‐1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Aboubakr HA, Sharafeldin TA, Goyal SM. Stability of SARS‐CoV‐2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review. Transbound Emerg Dis. 2020:1‐17. 10.1111/tbed.13707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Riddell S, Goldie S, Hill A, Eagles D, Drew TW. The effect of temperature on persistence of SARS‐CoV‐2 on common surfaces. Virol J. 2020;17:1‐7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Duan S, Zhao X, Wen R, et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci. 2003;16:246. [PubMed] [Google Scholar]
- 20. Bu J, Peng D‐D, Xiao H, et al. Analysis of meteorological conditions and prediction of epidemic trend of 2019‐nCoV infection in 2020. medRxiv. 2020. 10.1101/2020.02.13.20022715. [DOI] [Google Scholar]
- 21. Auberger S. Biocidal products. Google Patents. 2017.
- 22. Wigginton KR, Pecson BM, Sigstam T, Bosshard F, Kohn T. Virus inactivation mechanisms: impact of disinfectants on virus function and structural integrity. Environ Sci Technol. 2012;46:12069‐12078. [DOI] [PubMed] [Google Scholar]
- 23. L'Huillier A, Tapparel C, Turin L, Boquete‐Suter P, Thomas Y, Kaiser L. Survival of rhinoviruses on human fingers. Clin Microbiol Infect. 2015;21:381‐385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Rabenau H, Cinatl J, Morgenstern B, Bauer G, Preiser W, Doerr H. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol. 2005;194:1‐6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Siddharta A, Pfaender S, Vielle NJ, et al. Virucidal activity of World Health Organization–recommended formulations against enveloped viruses, including Zika, Ebola, and emerging coronaviruses. J Infect Dis. 2017;215:902‐906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Rabenau H, Kampf G, Cinatl J, Doerr H. Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect. 2005;61:107‐111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Saknimit M, Inatsuki I, Sugiyama Y, Yagami K‐I. Virucidal efficacy of physico‐chemical treatments against coronaviruses and parvoviruses of laboratory animals. Exp Anim. 1988;37:341‐345. [DOI] [PubMed] [Google Scholar]
- 28. Kratzel A, Todt D, V'kovski P, et al. Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO‐recommended hand rub formulations and alcohols. Emerg Infect Dis. 2020;26:1592‐1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Eggers M, Koburger‐Janssen T, Eickmann M, Zorn J. In vitro bactericidal and virucidal efficacy of povidone‐iodine gargle/mouthwash against respiratory and oral tract pathogens. Infect Dis Ther. 2018;7:249‐259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Sattar S, Springthorpe V, Karim Y, Loro P. Chemical disinfection of non‐porous inanimate surfaces experimentally contaminated with four human pathogenic viruses. Epidemiol Infect. 1989;102:493‐505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Anderson DE, Sivalingam V, Kang AEZ, et al. Povidone‐iodine demonstrates rapid in‐vitro virucidal activity against SARS‐CoV‐2, the virus causing COVID‐19 disease. 2020. [DOI] [PMC free article] [PubMed]
- 32. Geller C, Fontanay S, Mourer M, et al. Antiseptic properties of two calix [4] arene derivatives on the human coronavirus 229E. Antiviral Res. 2010;88:343‐346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev. 2004;17:863‐893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Mecenas P, Bastos R, Vallinoto A, Normando D. Effects of temperature and humidity on the spread of COVID‐19: a systematic review. PLoS One. 2020;15:e0238339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Rutala WA, Weber DJ. Guideline for disinfection and sterilization in healthcare facilities, 2008. 2008.
- 36. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 2001;14:227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Lai MY, Cheng PK, Lim WW. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis. 2005;41:e67‐e71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone‐iodine, physical conditions, and chemical reagents. Jpn J Vet Res. 2004;52:105‐112. [PubMed] [Google Scholar]
- 39. Enjuanes L, Almazán F, Sola I, Zuñiga S. Biochemical aspects of coronavirus replication and virus‐host interaction. Annu Rev Microbiol. 2006;60:211‐230. [DOI] [PubMed] [Google Scholar]
- 40. Ijaz MK, Whitehead K, Srinivasan V, et al. Microbicidal actives with virucidal efficacy against SARS‐CoV‐2. Am J Infect Control. 2020;48:972‐973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone‐iodine, physical conditions and chemical reagents. Dermatology. 2006;212:119‐123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Geller C, Varbanov M, Duval RE. Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies. Viruses. 2012;4:3044‐3068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Wang Y, Wu X, Wang Y, et al. Low stability of nucleocapsid protein in SARS virus. Biochemistry. 2004;43:11103‐11108. [DOI] [PubMed] [Google Scholar]
- 44. Darnell ME, Subbarao K, Feinstone SM, Taylor DR. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS‐CoV. J Virol Methods. 2004;121:85‐91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Chan K, Peiris J, Lam S, Poon L, Yuen K, Seto W. The effects of temperature and relative humidity on the viability of the SARS coronavirus. Adv Virol. 2011;2011:1‐7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Wang T, Lien C, Liu S, Selveraj P. Effective Heat Inactivation of SARS‐CoV‐2. medRxiv. 2020. 10.1101/2020.04.29.20085498. [DOI] [Google Scholar]
- 47. Leclercq I, Batejat C, Burguière AM, Manuguerra JC. Heat inactivation of the Middle East respiratory syndrome coronavirus. Influenza Other Respi Viruses. 2014;8:585‐586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Pastorino B, Touret F, Gilles M, de Lamballerie X, Charrel RN. Heat inactivation of different types of SARS‐CoV‐2 samples: what protocols for biosafety, molecular detection and serological diagnostics? Viruses. 2020;12:735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Van Doremalen N, Bushmaker T, Munster V. Stability of Middle East respiratory syndrome coronavirus (MERS‐CoV) under different environmental conditions. Eurosurveillance. 2013;18:20590. [DOI] [PubMed] [Google Scholar]
- 50. Chan K‐H, Sridhar S, Zhang RR, et al. Factors affecting stability and infectivity of SARS‐CoV‐2. J Hosp Infect. 2020;106:226‐231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Bedell K, Buchaklian AH, Perlman S. Efficacy of an automated multiple emitter whole‐room ultraviolet‐C disinfection system against coronaviruses MHV and MERS‐CoV. Infect Control Hosp Epidemiol. 2016;37:598‐599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Heilingloh CS, Aufderhorst UW, Schipper L, et al. Susceptibility of SARS‐CoV‐2 to UV irradiation. Am J Infect Control. 2020;48:1273‐1275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Organization WH . Water, Sanitation, Hygiene and Waste Management for COVID‐19: Technical Brief, March 3, 2020. Geneva: World Health Organization; 2020. [Google Scholar]
- 54. Yari S, Moshammer H, Asadi AF. Side effects of using disinfectants to fight COVID‐19. Asian Pac J Environ Cancer. 2020;3:9‐13. [Google Scholar]
- 55. Lamarre A, Talbot PJ. Effect of pH and temperature on the infectivity of human coronavirus 229E. Can J Microbiol. 1989;35:972‐974. [DOI] [PubMed] [Google Scholar]
- 56. Regnard J. Cold and the airways. Int J Sports Med. 1992;13:S182‐S184. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All the data reported in this manuscript are derived from published articles.
